These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 996424)
1. [Hepatitis B antigens in the blood of pregnant women compared with those in umbilical cord blood]. Pappo A; Tănăsesco C; Roman L Med Interne; 1976; 14(4):275-7. PubMed ID: 996424 [No Abstract] [Full Text] [Related]
10. [Australia antigen in the amniotic fluid]. Palacios Mateos JM; Pato Castel I; Salmerón de Diego J; García Robles R; Moreno Esteban B; Lorente Fernández L Rev Clin Esp; 1972 Sep; 126(6):539-40. PubMed ID: 4658359 [No Abstract] [Full Text] [Related]
11. Hepatitis-associated antigen (Australia antigen) in mother and infant. Schweitzer IL; Spears RL N Engl J Med; 1970 Sep; 283(11):570-2. PubMed ID: 4988917 [No Abstract] [Full Text] [Related]
12. [Detection of HAA in samples of materno-fetal blood]. Badolati G; Leone G; Caffarello S G Ig Med Prev; 1971; 12(1):77-82. PubMed ID: 5005042 [No Abstract] [Full Text] [Related]
13. [Incidence of the HBsAg carrier state among pregnant women and its effect on the newborn infant. II. The presence of hepatitis B and delta markers in the umbilical cord serum of infants born to mothers who are HBsAg carriers]. Iliev B; Stambolov B; Khristov M Akush Ginekol (Sofiia); 1987; 26(5):22-5. PubMed ID: 3434699 [No Abstract] [Full Text] [Related]
14. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis. Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071 [TBL] [Abstract][Full Text] [Related]
15. [The transfer of hepatitis B virus (HBV) from HBsAg(+) mothers to their babies]. Mistik R; Baran B Mikrobiyol Bul; 1993 Apr; 27(2):143-6. PubMed ID: 8502186 [TBL] [Abstract][Full Text] [Related]
16. [Maternal-fetal transmission of infection with hepatitis B virus: evaluation of viral markers in maternal and fetal biological materials and relation with the vaccine response]. Damiani S; Attanasio P; Maneschi F; Speciale P; La Ferla A; Navetta A; Tripi S; Migneco G Ann Ostet Ginecol Med Perinat; 1989; 110(5):217-25. PubMed ID: 2534523 [TBL] [Abstract][Full Text] [Related]
17. Letter: Infectiosity of HB Ag carriers? Skinhoj P Gastroenterology; 1974 May; 66(5):1102. PubMed ID: 4826991 [No Abstract] [Full Text] [Related]
18. [Possibility of transplacental passage of the Australia antigen]. Pilotti G; Pennacino G; Trapani C Minerva Pediatr; 1976 Apr; 28(14):856-63. PubMed ID: 995095 [No Abstract] [Full Text] [Related]
19. The effects of hepatitis A and B in pregnancy on mother and fetus. Shwer M; Moosa A S Afr Med J; 1978 Dec; 54(26):1092-5. PubMed ID: 371031 [TBL] [Abstract][Full Text] [Related]
20. Transplacental lactate dehydrogenase-elevating virus (LDV) transmission: immune inhibition of umbilical cord infection, and correlation of fetal virus susceptibility with development of F4/80 antigen expression. Zitterkopf NL; Haven TR; Huela M; Bradley DS; Cafruny WA Placenta; 2002 May; 23(5):438-46. PubMed ID: 12061860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]